Delivery Order SPE2DR25D2102-SPE2DR26FB2FA
Award Date 11/17/25
Potential Completion Date 11/18/25
Potential Value $5.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $4,529.19 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of 36,000 units of Creon DR 100s capsules, with completion targeted for September 16, 2025. This firm fixed-price contract represents a non-competitive set-aside award and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic insufficiency, indicating this delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,088.91 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100 mg capsules. This non-competitive, firm fixed price delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. As a child contract under a larger vehicle, this delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $25,167.42 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules under a firm fixed-price contract. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order utilizing the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. Creon is a pancreatic enzyme replacement therapy used to treat pancreatic...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,004.53 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100 capsules, with an ultimate completion date of July 30, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, awarded competitively on July 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Creon DR is an enzyme replacement therapy used to treat...
- The Defense Logistics Agency awarded a delivery order valued at $77,595.73 to AmerisourceBergen Drug Corp for 36,000 units of Creon DR 100s capsules. This non-competitive delivery order, issued on November 3, 2025, represents a firm fixed price procurement with a completion date of November 4, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The contract is classified as a child order under a larger contract...
- The Defense Logistics Agency awarded a $20,143.64 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of 36,000 units of Creon DR 100 strength capsules. The contract is classified as a non-set-aside, competitively awarded delivery order with firm fixed pricing and is scheduled for completion by June 26, 2025. Performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $14,406.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for 36,000 unit capsules of Creon (pancrelipase) in 100-count packages, with completion scheduled for September 10, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-set-aside and was...
- The Defense Logistics Agency awarded a delivery order valued at $42,783.63 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of 36,000 units of Creon DR 100s capsules. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award, and is scheduled for completion by August 20, 2025. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a $1,551.61 delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100 units. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procurement procedures. The order is scheduled for completion by November 18, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is executed...
- The Defense Logistics Agency awarded a $14,612.52 firm fixed-price delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Creon DR 36,000 unit capsules in quantities of 100s. The contract, with an ultimate completion date of November 18, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was not designated as a...